Designing better ways to deliver drugs HST MEMP PhD candidate and MathWorks Fellow Louis DeRidder is developing a device to make chemotherapy dosing more accurate for individual patients. Rallying around graduate student parents From helping new parents to coordinating play dates and sharing information, MIT students who are parents are there for one another. Designing better delivery for medical therapies HST MD/PhD student Sayo Eweje seeks to develop new technologies for delivering RNA and protein therapies directly to the body’s cells. HST MD grad Alaleh Azhir’s mission: exploring and improving health care delivery for women Her goal is to investigate how health conditions may present differently by gender, and how to devise more effective treatments for women accordingly. HST MEMP grad Carmen Martin Alonso looks ahead to a bright future as a medical researcher Awarded a provisional patent for her work on liquid biopsy “priming agents,” Martin Alonso hopes to soon be the founding scientist of a start-up. Pagination Current page 1 Page 2 Page 3 Page 4 Page 5 Page 6 Page 7 … Next page Next Last page Last »
Designing better ways to deliver drugs HST MEMP PhD candidate and MathWorks Fellow Louis DeRidder is developing a device to make chemotherapy dosing more accurate for individual patients.
Rallying around graduate student parents From helping new parents to coordinating play dates and sharing information, MIT students who are parents are there for one another.
Designing better delivery for medical therapies HST MD/PhD student Sayo Eweje seeks to develop new technologies for delivering RNA and protein therapies directly to the body’s cells.
HST MD grad Alaleh Azhir’s mission: exploring and improving health care delivery for women Her goal is to investigate how health conditions may present differently by gender, and how to devise more effective treatments for women accordingly.
HST MEMP grad Carmen Martin Alonso looks ahead to a bright future as a medical researcher Awarded a provisional patent for her work on liquid biopsy “priming agents,” Martin Alonso hopes to soon be the founding scientist of a start-up.
